Table 1.
Effect of SRC1 ASO on various metabolic parameters in regular chow-fed rats
Control ASO | SRC1 ASO | P Value | |
---|---|---|---|
Epidydimal adipose tissue weight, g | 2.35 ± 0.22 | 2.15 ± 0.31 | 0.62 |
Plasma triglyceride, mg/dl | 16.5 ± 2.14 | 16.2 ± 1.47 | 0.93 |
Plasma NEFA, mmol/l | 0.76 ± 0.05 | 0.68 ± 0.04 | 0.21 |
Plasma AST, U/l | 95.6 ± 15.04 | 72.7 ± 6.48 | 0.15 |
Plasma ALT, U/l | 40.6 ± 4.62 | 31.3 ± 4.08 | 0.17 |
Basal glucagon, pg/ml | 18.4 ± 5.7 | 23.5 ± 4.3 | 0.50 |
Liver triglyceride, mg/g tissue | 6.98 ± 1.29 | 6.9 ± 1.06 | 0.96 |
Gastrocnemius muscle triglyceride, mg/g tissue | 3.78 ± 0.99 | 1.85 ± 0.57 | 0.13 |
Values are means ± SE; n = 5–6/group. SRC1, steroid receptor coactivator 1; ASO, antisense oligonucleotide; NEFA, nonesterified fatty acid; AST, aspartate aminotransferase; ALT, alanine aminotransferase. Glucagon was measured in overnight-fasted rats treated with control or SRC1 ASO for 4 wk. All other parameters were determined in hyperinsulinemic euglycemic-clamped rats. P value calculated by Student's t-test.